KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review
{{output}}
Introduction: As epigenetic modulators, histone demethylases can be a therapeutic target in the area of oncology. KDM4 subfamily proteins are histone demethylases with a Jumonji domain. The subfamily consists of five functional m... ...
